BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30481375)

  • 1. Updates in adjuvant systemic therapy for melanoma.
    Kwak M; Farrow NE; Salama AKS; Mosca PJ; Hanks BA; Slingluff CL; Beasley GM
    J Surg Oncol; 2019 Jan; 119(2):222-231. PubMed ID: 30481375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Treatments for Advanced Resectable Melanoma.
    Liu JY; Lowe M
    J Surg Oncol; 2019 Jan; 119(2):216-221. PubMed ID: 30589079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma.
    Fukumoto T; Horita N
    Eur J Cancer; 2021 Apr; 147():140-141. PubMed ID: 33662688
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug clinics. How I treat cutaneous melanoma].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 1998 Jan; 53(1):4-6. PubMed ID: 9555173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of melanoma combination immunotherapy.
    Baker H
    Lancet Oncol; 2017 Oct; 18(10):e565. PubMed ID: 28870612
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant immunotherapy for melanoma.
    Thomas D; Bello DM
    J Surg Oncol; 2021 Mar; 123(3):789-797. PubMed ID: 33595889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of melanoma.
    Brown CK; Kirkwood JM
    Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in the management of advanced cutaneous malignant melanoma.
    Luke JJ; Schwartz GK
    Clin Dermatol; 2013; 31(3):290-7. PubMed ID: 23608448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma trials that defined surgical management: Brief overview of current/upcoming adjuvant/neoadjuvant trials.
    Patel A; Skitzki J
    J Surg Oncol; 2022 Jan; 125(1):38-45. PubMed ID: 34897704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy of malignant melanoma.
    Seeger J; Richman SP; Allegra JC
    Med Clin North Am; 1986 Jan; 70(1):89-94. PubMed ID: 3510351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant immunotherapy: the sting in the tail.
    Higham CE; Chatzimavridou-Grigoriadou V; Fitzgerald CT; Trainer PJ; Eggermont AMM; Lorigan P
    Eur J Cancer; 2020 Jun; 132():207-210. PubMed ID: 32388064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review.
    Baetz TD; Fletcher GG; Knight G; McWhirter E; Rajagopal S; Song X; Petrella TM
    Cancer Treat Rev; 2020 Jul; 87():102032. PubMed ID: 32473511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.
    McQuade JL; Daniel CR; Hess KR; Mak C; Wang DY; Rai RR; Park JJ; Haydu LE; Spencer C; Wongchenko M; Lane S; Lee DY; Kaper M; McKean M; Beckermann KE; Rubinstein SM; Rooney I; Musib L; Budha N; Hsu J; Nowicki TS; Avila A; Haas T; Puligandla M; Lee S; Fang S; Wargo JA; Gershenwald JE; Lee JE; Hwu P; Chapman PB; Sosman JA; Schadendorf D; Grob JJ; Flaherty KT; Walker D; Yan Y; McKenna E; Legos JJ; Carlino MS; Ribas A; Kirkwood JM; Long GV; Johnson DB; Menzies AM; Davies MA
    Lancet Oncol; 2018 Mar; 19(3):310-322. PubMed ID: 29449192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients.
    Eggermont AMM; Dummer R
    Eur J Cancer; 2017 Nov; 86():101-105. PubMed ID: 28968566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant chemotherapy in the combined treatment of primary circumscribed malignant melanoma of the skin].
    Korovin SI
    Lik Sprava; 1998 May; (3):114-7. PubMed ID: 9695586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current aspects in the prognosis of advanced melanoma].
    Sirokay-Kohlmeyer J
    Hautarzt; 2018 Mar; 69(3):249-259. PubMed ID: 29396638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New hope in metastatic melanoma treatment?].
    Guillot B
    Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of nivolumab in melanoma.
    Gomes F; Serra-Bellver P; Lorigan P
    Future Oncol; 2018 Jun; 14(13):1241-1252. PubMed ID: 29328782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Mateus C; Libenciuc C; Robert C
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S4-S11. PubMed ID: 27494973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.